Investor Relations

Investors

The Future of High-Stakes Surgical Decision-Making

Why Verus

Most patients agree to heart surgery after just one rushed consultation.

Their imaging is barely reviewed.

Their second opinion - if they get one - is often from the same hospital that stands to benefit from the operation.

Verus is the first AI-augmented, surgeon-verified, blockchain-authenticated second opinion platform for cardiac surgery.

We are building a new standard for high-risk patient decisions - where AI accelerates clarity, surgeons anchor trust, and every report is tamper-proof.

Our Mission

To restore trust in the most dangerous corner of medicine: open-heart surgery.
To prevent unnecessary procedures.
To help patients make better decisions.
To document everything—so it can never be altered.

Market Opportunity

$500B+ spent annually on invasive procedures
Up to 30% may be unnecessary
$4.6B global second opinion market
400,000+ open-heart surgeries per year in the U.S. alone
Rising demand for independent guidance, AI triage, and patient-controlled data

Verus targets a critical, underserved gap

Our Solution

AI-based triage (Scout, Pulse)
Human-surgeon verification (Command)
Blockchain-authenticated reports
Verus Verified™ credentialing for MDs
Concierge wraparound care
DTC + referral + platform licensing revenue streams

Scope of Opinions

Verus reports do not constitute surgical orders, hospital admission directives, or insurance
authorizations
We do not prescribe medications or make real-time inpatient decisions
Our service is consultative and educational in nature - not directive or interventional

What Sets Us Apart

Feature	Traditional Second Opinion	Verus
Surgeon Independence	Often embedded in hospital	Fully independent
AI Risk Calculation	Rare or absent	Integrated STS + NLP AI layer
Guideline Mapping	Often omitted	Required on every report
Blockchain Verification	None	SHA256 + timestamp on-chain
Concierge Support	Not Available	24/7 in premium tiers
Revenue Model	Fee-for-service or internal	Multi-channel + scalable

Early Traction

Platform and AI agents fully built
Website and intake system live
Surgeon network onboarded
First patients and testimonials received
Legal / ethical frameworks locked in
Strong investor interest from physician and health-tech networks

Investment Opportunity

Seeking pre-seed or bridge round: $250K -$500K
Instrument: SAFE with discount
Instrument: SAFE with discount
Funds used for:

AI optimization
Legal compliance
Concierge expansion
Growth marketing
B2B pilots

Why Now

AI is finally clinically safe for triage
Patients demand second opinions and data transparency
Hospitals are losing trust
Litigation and risk are driving change
Verus is the right company - at the right moment

Join Us

Request our investor deck
Schedule a call with Founders
See Live Demo or Case Walkthrough

Contact Us

You may reach us by email here.

Your incision should be your decision.

Investment Opportunities in Advanced Cardiac Consultation